NewsHempHemp Space Trial Is Out Of This World

Hemp Space Trial Is Out Of This World

-

HEMP cultures have been fired into space to see how they react to a zero-gravity environment.

Around 480 hemp and coffee cultures were carried on Elon Musk’s SpaceX rocket for cultivation in the International Space Station in early March.

Provided by Front Range Biosciences their growth will be monitored remotely, and they will returned to earth for analysis.

Front Range, SpaceCells and BioServe Space Technologies at the University of Colorado, Boulder, are behind the SpaceX CRS-20 cargo flight.

The backers say the advent of private space travel has opened up a new area known as ‘new space’, which allows researchers to study the effects of micro-gravity on a variety of organisms.

With the earth’s climate subject to fluctuations the research will look at how crops can thrive in a scenario of shifting temperatures. 

BioServe says it will work with the NASA astronauts to execute the experiment, with the cultures being monitored remotely from its payload operations center in Boulder. 

Dr. Jonathan Vaught, Co-Founder and CEO of Front Range Biosciences said science supports the theory that ‘plants in space experience mutations’. 

Adding: “This is an opportunity to see whether those mutations hold up once brought back to earth and if there are new commercial applications.”  

Peter McCullagh, CEO of SpaceCells,  said: “These are big ideas we’re pursuing and there’s a massive opportunity to bring to market new Chemotypes, as well as plants that can better adapt to drought and cold conditions.  

“We expect to prove through these and other missions that we can adapt the food supply to climate change.”

The International Space Station is a $100bn science and engineering laboratory that orbits 250 miles above Earth.

Permanently staffed it conducts research into space medicine, life sciences, physical sciences, astronomy and meteorology.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

Must read

You might also likeRELATED
Recommended to you